NL6607516A - - Google Patents

Info

Publication number
NL6607516A
NL6607516A NL6607516A NL6607516A NL6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A NL 6607516 A NL6607516 A NL 6607516A
Authority
NL
Netherlands
Application number
NL6607516A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to NL6607516A priority Critical patent/NL6607516A/xx
Priority to FR82837A priority patent/FR5953M/fr
Priority to GB22620/67A priority patent/GB1131007A/en
Priority to SE06961/67A priority patent/SE354417B/xx
Priority to IL28009A priority patent/IL28009A/en
Priority to GR670133861A priority patent/GR33861B/el
Priority to ES340956A priority patent/ES340956A1/es
Priority to SU1158241A priority patent/SU510986A3/ru
Priority to US641483A priority patent/US3557280A/en
Priority to BE699091D priority patent/BE699091A/xx
Priority to DE1617576A priority patent/DE1617576C3/de
Priority to YU1086/67A priority patent/YU31326B/xx
Priority to NO00168375A priority patent/NO126298B/no
Priority to FR108345A priority patent/FR1529966A/fr
Priority to FI1517/67A priority patent/FI43622B/fi
Priority to IT37118/67A priority patent/IT1140250B/it
Priority to DK282167AA priority patent/DK117587B/da
Priority to AT502267A priority patent/AT272522B/de
Priority to JP42034292A priority patent/JPS5010373B1/ja
Priority to CS3970A priority patent/CS151454B2/cs
Priority to LU53788A priority patent/LU53788A1/xx
Priority to CH766867A priority patent/CH490087A/de
Publication of NL6607516A publication Critical patent/NL6607516A/xx
Priority to MY15/71A priority patent/MY7100015A/xx
Priority to US05/267,087 priority patent/US3957972A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A61K31/79—Polymers of vinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NL6607516A 1966-05-31 1966-05-31 NL6607516A (ko)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (ko) 1966-05-31 1966-05-31
FR82837A FR5953M (ko) 1966-05-31 1966-11-08
GB22620/67A GB1131007A (en) 1966-05-31 1967-05-16 Improvements in or relating to aqueous solutions of oxytetracycline
SE06961/67A SE354417B (ko) 1966-05-31 1967-05-18
IL28009A IL28009A (en) 1966-05-31 1967-05-18 Process for the preparation of stable solutions of oxytetracycline in water,suitable for parenteral and peroral administration
GR670133861A GR33861B (el) 1966-05-31 1967-05-22 Μεθοδος δια την παρασκευην σταθερων εν των υδατι διαλυματων οξυτερακυκλινης, καταλληλων δια την παρεντερικην και την δια του στοματος χορηγησιν.
ES340956A ES340956A1 (es) 1966-05-31 1967-05-24 Procedimiento para la preparacion de soluciones estables deoxitetraciclina en agua adecuadas para administracion paren-teral, peronal y local.
SU1158241A SU510986A3 (ru) 1966-05-31 1967-05-25 Способ получени раствора окситетрациклина
US641483A US3557280A (en) 1966-05-31 1967-05-26 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation
BE699091D BE699091A (ko) 1966-05-31 1967-05-26
DE1617576A DE1617576C3 (de) 1966-05-31 1967-05-26 Verfahren zur Herstellung eines Injektionspräparates auf Basis einer wäßrigen Lösung eines Oxytetracyclin-Magnesium-Komplexes
YU1086/67A YU31326B (en) 1966-05-31 1967-05-30 Postupak za dobijanje stabilnog vodenog rastvora oksitetraciklina pogodnog za parenteralnu, peroralnu i lokalnu upotrebu
NO00168375A NO126298B (ko) 1966-05-31 1967-05-30
FR108345A FR1529966A (fr) 1966-05-31 1967-05-30 Procédé de préparation de solutions aqueuses stables d'oxytétracycline
FI1517/67A FI43622B (ko) 1966-05-31 1967-05-30
IT37118/67A IT1140250B (it) 1966-05-31 1967-05-30 Procedimento per la preparazione di soluzioni stabili di ossitetraciclina in acqua, adatte per somministrazioni per via parenterale ed orale
DK282167AA DK117587B (da) 1966-05-31 1967-05-30 Fremgangsmåde til fremstilling af stabile vandige opløsninger af oxytetracyclin egnet til parenteral, peroral og topisk indgivelse.
AT502267A AT272522B (de) 1966-05-31 1967-05-30 Verfahren zur Herstellung von stabilen, für die parenterale und perorale Verabreichung geeigneten wässerigen Lösungen von Oxytetracyclin
JP42034292A JPS5010373B1 (ko) 1966-05-31 1967-05-31
CS3970A CS151454B2 (ko) 1966-05-31 1967-05-31
LU53788A LU53788A1 (ko) 1966-05-31 1967-05-31
CH766867A CH490087A (de) 1966-05-31 1967-05-31 Verfahren zur Herstellung von stabilen, für die parenterale, perorale und lokale Verabreichung geeigneten wässrigen Oxytetracyclinlösungen
MY15/71A MY7100015A (en) 1966-05-31 1971-12-30 Improvements in or relating to aqueous solutions of oxytetracycline
US05/267,087 US3957972A (en) 1966-05-31 1972-06-28 Stable solutions of oxytetracycline suitable for parenteral and peroral administration and process of preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6607516A NL6607516A (ko) 1966-05-31 1966-05-31

Publications (1)

Publication Number Publication Date
NL6607516A true NL6607516A (ko) 1967-12-01

Family

ID=19796753

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6607516A NL6607516A (ko) 1966-05-31 1966-05-31

Country Status (22)

Country Link
US (1) US3557280A (ko)
JP (1) JPS5010373B1 (ko)
AT (1) AT272522B (ko)
BE (1) BE699091A (ko)
CH (1) CH490087A (ko)
CS (1) CS151454B2 (ko)
DE (1) DE1617576C3 (ko)
DK (1) DK117587B (ko)
ES (1) ES340956A1 (ko)
FI (1) FI43622B (ko)
FR (1) FR5953M (ko)
GB (1) GB1131007A (ko)
GR (1) GR33861B (ko)
IL (1) IL28009A (ko)
IT (1) IT1140250B (ko)
LU (1) LU53788A1 (ko)
MY (1) MY7100015A (ko)
NL (1) NL6607516A (ko)
NO (1) NO126298B (ko)
SE (1) SE354417B (ko)
SU (1) SU510986A3 (ko)
YU (1) YU31326B (ko)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5418330B2 (ko) * 1973-03-16 1979-07-06
US3966905A (en) * 1973-05-29 1976-06-29 Barnes-Hind Pharmaceuticals, Inc. Stabilized catechol amine solutions
US3929989A (en) * 1974-06-14 1975-12-30 Wendt Lab Inc Stable suspension of calcium-magnesium oxytetracycline for intrauterine administration in treatment of bovine metritis
US4018889A (en) * 1976-01-02 1977-04-19 Pfizer Inc. Oxytetracycline compositions
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
GB1592053A (en) * 1976-12-16 1981-07-01 Norbrook Lab Ltd Oxytetracycline compositions
US4213963A (en) * 1978-12-14 1980-07-22 Janssen Pharmaceutica N.V. Fluspirilene-containing compositions
US4259331A (en) * 1979-04-16 1981-03-31 Pfizer Inc. Oxytetracycline compositions
US4399127A (en) * 1980-04-10 1983-08-16 Diamond Shamrock Corporation Injectable oxytetracycline compositions
US4386083A (en) * 1980-04-10 1983-05-31 Walter Hacke Injectable oxytetracycline compositions
IE74244B1 (en) * 1985-10-01 1997-07-16 Bimeda Res Dev Ltd A process for preparing an antibiotic composition
US5071643A (en) * 1986-10-17 1991-12-10 R. P. Scherer Corporation Solvent system enhancing the solubility of pharmaceuticals for encapsulation
US6756365B2 (en) * 1991-11-06 2004-06-29 Trustees Of Tufts College Reducing tetracycline resistance in living cells
EP0626171A1 (de) * 1993-05-26 1994-11-30 Winfried Dörnhöfer Injektionslösung für die intravenöse oder intramuskuläre Verabreichung an Tiere
US6383515B2 (en) 1999-05-28 2002-05-07 Sawyer Maryjean Solvent system for enhancing solubility
US6500812B2 (en) 1999-09-14 2002-12-31 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
US8106225B2 (en) * 1999-09-14 2012-01-31 Trustees Of Tufts College Methods of preparing substituted tetracyclines with transition metal-based chemistries
US6849615B2 (en) 1999-09-14 2005-02-01 Paratek Pharmaceuticals, Inc. 13-substituted methacycline compounds
DE60027465T2 (de) 1999-09-14 2007-02-01 The Trustees Of Tufts College, Medford Verfahren zur herstellung von substituierten tetracyclinen mit hilfe von auf übergangsmetalle basierten chemien
WO2001052858A1 (en) * 2000-01-24 2001-07-26 Trustees Of Tufts College Tetracycline compounds for treatment of cryptosporidium parvum related disorders
CA2404628A1 (en) * 2000-03-31 2001-10-11 Stuart B. Levy 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds
EP2308863A1 (en) * 2000-05-15 2011-04-13 Paratek Pharmaceuticals, Inc. 7-substituted fused ring tetracycline compounds
US20040224927A1 (en) * 2000-06-16 2004-11-11 Trustees Of Tufts College 7-N-substituted phenyl tetracycline compounds
US20020132798A1 (en) * 2000-06-16 2002-09-19 Nelson Mark L. 7-phenyl-substituted tetracycline compounds
AU2001268475A1 (en) * 2000-06-16 2002-01-02 Trustees Of Tufts College 7-phenyl-substituted tetracycline compounds
WO2002004405A2 (en) 2000-07-07 2002-01-17 Trustees Of Tufts College 13-substituted methacycline compounds
US7094806B2 (en) * 2000-07-07 2006-08-22 Trustees Of Tufts College 7, 8 and 9-substituted tetracycline compounds
CN1690047B (zh) 2000-07-07 2010-10-06 塔夫茨大学信托人 9-取代的二甲胺四环素化合物
KR101083571B1 (ko) 2000-07-07 2011-11-14 파라테크 파마슈티컬스, 인크. 7-치환 테트라사이클린 화합물
US20050143353A1 (en) * 2000-07-07 2005-06-30 Paratek Pharmaceuticals, Inc. 13-Substituted methacycline compounds
EP2166000A1 (en) 2000-07-07 2010-03-24 Trustees Of Tufts College 7-, 8- and 9-substituted tetracycline compounds
BR0116935A (pt) 2001-03-13 2005-04-12 Paratek Pharm Innc Composto de tetraciclina, método para tratar um estado responsivo à tetraciclina em um indivìduo, e, composição farmacêutica
AU2002250331A1 (en) * 2001-03-13 2002-09-24 Paratek Pharmaceuticals, Inc. 7-pyrollyl tetracycline compounds and methods of use thereof
US6841546B2 (en) 2001-03-14 2005-01-11 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds as antifungal agents
JP2005504722A (ja) 2001-03-14 2005-02-17 パラテック ファーマシューティカルズ インコーポレイテッド 相乗的抗真菌薬剤としての置換テトラサイクリン化合物
AU2002254714C1 (en) 2001-04-24 2010-01-07 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
US8088820B2 (en) * 2001-04-24 2012-01-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
JP2005514410A (ja) 2002-01-08 2005-05-19 パラテック ファーマシューティカルズ インコーポレイテッド ４−デジメチルアミノテトラサイクリン化合物
AU2003220123B2 (en) 2002-03-08 2009-05-07 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
CN101712632A (zh) 2002-03-21 2010-05-26 帕拉特克药品公司 取代的四环素化合物
CN1700922A (zh) 2002-07-12 2005-11-23 帕拉特克药品公司 3、10或12a位取代的四环素化合物
AU2003287218C1 (en) 2002-10-24 2010-07-15 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for the treatment of malaria
EP1605916A4 (en) * 2003-02-12 2012-02-22 R & P Korea Co Ltd SOLUBENT SOLVENT SYSTEM WITH SOLUBLE PEEL WITH IMPROVED ELUTION RATE
CA2531732C (en) 2003-07-09 2012-04-10 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
US20060287283A1 (en) * 2003-07-09 2006-12-21 Paratek Pharmaceuticals, Inc. Prodrugs of 9-aminomethyl tetracycline compounds
CA2531728A1 (en) 2003-07-09 2005-02-03 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
US7786099B2 (en) * 2004-01-15 2010-08-31 Paratek Pharmaceuticals, Inc. Aromatic a-ring derivatives of tetracycline compounds
TWI261038B (en) * 2004-08-11 2006-09-01 Bo-Cheng Chen Bicycle gear-shifting handgrip
EP1805134B1 (en) 2004-10-25 2012-06-20 Paratek Pharmaceuticals, Inc. 4-aminotetracyclines and methods of use thereof
EP2295419A3 (en) 2004-10-25 2011-09-21 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
CA2597212A1 (en) * 2005-02-04 2006-08-10 Paratek Pharmaceuticals, Inc. 11a, 12-derivatives of tetracycline compounds
DE102005012595A1 (de) * 2005-03-18 2006-09-21 Lanxess Deutschland Gmbh Herstellung von Tri(chlorpropyl)phosphat
WO2007014154A2 (en) * 2005-07-21 2007-02-01 Paratek Pharmaceuticals, Inc. 10-substituted tetracyclines and methods of use thereof
CA2622704A1 (en) * 2005-09-19 2007-03-29 Albemarle Corporation Highly concentrated pourable aqueous solutions of potassium ibuprofen their preparation and their uses
EP1991236A2 (en) * 2006-01-24 2008-11-19 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
WO2007120913A2 (en) * 2006-04-17 2007-10-25 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
DK2016045T3 (en) * 2006-04-24 2015-02-02 Teva Pharma TIGECYCLIN CRYSTAL FORM AND PROCEDURES FOR PREPARING IT
US20080118979A1 (en) * 2006-05-15 2008-05-22 Paratek Pharmaceuticals, Inc. Methods of regulating expression of genes or of gene products using substituted tetracycline compounds
WO2008045507A2 (en) 2006-10-11 2008-04-17 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of bacillus anthracis infections
PL2109602T3 (pl) 2006-12-21 2014-09-30 Paratek Pharm Innc Pochodne tetracyliny do leczenia zakażeń bakteryjnych, wirusowych i pasożytniczych
EP2120963B1 (en) 2006-12-21 2018-09-12 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds for treatment of inflammatory skin disorders
JP2010523684A (ja) 2007-04-12 2010-07-15 パラテック ファーマシューティカルズ インコーポレイテッド テトラサイクリン化合物を用いる、脊髄筋委縮症を治療するための方法
US9434680B2 (en) * 2007-04-27 2016-09-06 Paratek Pharmaceuticals, Inc. Methods for synthesizing and purifying aminoalkyl tetracycline compounds
CA2693376A1 (en) 2007-07-06 2009-01-15 Paratek Pharmaceuticals, Inc. Methods for synthesizing substituted tetracycline compounds
MX2010009693A (es) * 2008-03-05 2010-12-20 Paratek Pharm Innc Compuestos de monociclina y metodos de uso de la misma.
PT2271348T (pt) 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
WO2009128913A1 (en) * 2008-04-14 2009-10-22 Paratek Pharmaceuticals, Inc. Substituted tetracycline compounds
TW202332671A (zh) * 2008-05-23 2023-08-16 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CA2730005C (en) 2008-07-21 2017-06-13 Albermarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
KR20110081197A (ko) * 2008-09-19 2011-07-13 파라테크 파마슈티컬스, 인크. 류마티스 관절염의 치료를 위한 테트라시클린 화합물 및 관련된 치료 방법
DE202010018378U1 (de) 2009-04-10 2016-04-07 Tufts Medical Center, Inc. PAR-1-Aktivierung durch Metalloproteinase-1 (MMP-1)
PL2707003T3 (pl) 2011-05-12 2019-11-29 Paratek Pharm Innc Krystaliczne sole amidu kwasu (4s,4as,5ar,12as)-4-dimetyloamino-3,10,12,12a-tetrahydroksy-7-[(metoksy(metylo)amino)metylo]-1,11-diokso- 1,4,4a,5,5a,6,11,12a-oktahydronaftaceno- 2-karboksylowego i sposoby ich stosowania
CN110087655A (zh) 2016-11-01 2019-08-02 帕拉特克药品公司 9-氨基甲基米诺环素化合物及其在治疗社区获得性细菌性肺炎(cabp)中的用途
WO2019016609A1 (en) 2017-07-21 2019-01-24 Allergan Pharmaceuticals International Limited TREATMENT OF NON-INFLAMMATORY LESIONS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2615140A1 (de) * 1975-04-11 1976-10-21 Nelson Res & Dev Vehiculumsystem

Also Published As

Publication number Publication date
AT272522B (de) 1969-07-10
FI43622B (ko) 1971-02-01
US3557280A (en) 1971-01-19
BE699091A (ko) 1967-11-27
MY7100015A (en) 1971-12-31
YU31326B (en) 1973-04-30
IL28009A (en) 1970-08-19
JPS5010373B1 (ko) 1975-04-21
CH490087A (de) 1970-05-15
SU510986A3 (ru) 1976-04-15
FR5953M (ko) 1968-04-16
DK117587B (da) 1970-05-11
GB1131007A (en) 1968-10-16
DE1617576B2 (de) 1980-04-10
SE354417B (ko) 1973-03-12
LU53788A1 (ko) 1967-07-31
DE1617576A1 (de) 1972-04-27
IT1140250B (it) 1986-09-24
DE1617576C3 (de) 1980-12-11
CS151454B2 (ko) 1973-10-19
NO126298B (ko) 1973-01-22
GR33861B (el) 1968-02-09
ES340956A1 (es) 1968-06-16

Similar Documents

Publication Publication Date Title
AT281852B (ko)
AU1141566A (ko)
AU1534566A (ko)
AU6703465A (ko)
AU1111066A (ko)
AU1144366A (ko)
AU218666A (ko)
AU1393566A (ko)
BE675139A (ko)
BE674777A (ko)
AU1027866A (ko)
BE694236A (ko)
BE694012A (ko)
BE693704A (ko)
BE693311A (ko)
BE692974A (ko)
BE692938A (ko)
BE692168A (ko)
BE691033A (ko)
BE689469A (ko)
BE689049A (ko)
BE688853A (ko)
BE687583A (ko)
BE678955A (ko)
BE694412A (ko)